financetom
Business
financetom
/
Business
/
Alexander's Q2 FFO, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alexander's Q2 FFO, Revenue Decrease
Aug 4, 2025 6:55 AM

09:17 AM EDT, 08/04/2025 (MT Newswires) -- Alexander's (ALX) reported Q2 funds from operations Monday of $2.88 per diluted share, down from $3.31 a year earlier.

A single analyst polled by FactSet expected $2.85.

Revenue for the quarter ended June 30 was $51.6 million, down from $53.4 million a year earlier.

A single analyst surveyed by FactSet expected $51.9 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intel Reportedly Partners With South Korea's Naver to Expand Gaudi-based Platform
Intel Reportedly Partners With South Korea's Naver to Expand Gaudi-based Platform
Jun 5, 2024
03:15 PM EDT, 06/05/2024 (MT Newswires) -- Intel ( INTC ) is partnering with South Korea's Naver to expand an open-platform software system based on the US company's Gaudi artificial- intelligence accelerator, according to multiple media reports Wednesday. The partnership was announced at Intel's ( INTC ) AI conference in Seoul. We have a fundamental view that open ecosystems enable...
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Jun 5, 2024
On Wednesday, the stocks of Madrigal Pharmaceuticals Inc ( MDGL ) and Sagimet Biosciences Inc ( SGMT ) are trading lower. At the EASL International Liver Congress 2024, Eli Lilly And Co ( LLY ) shared an abstract highlighting fibrosis results from a Phase 2 trial of tirzepatide in patients with metabolic dysfunction-associated steatohepatitis (MASH). Tirzepatide is a key ingredient...
Vanguard says it backed Exxon board, but cites investor rights concerns
Vanguard says it backed Exxon board, but cites investor rights concerns
Jun 5, 2024
June 5 (Reuters) - Vanguard said its funds supported the election of Exxon's director nominees at its annual meeting last week, but the mutual fund giant cited lingering concerns about the energy company's lawsuit against climate activists. All 12 of the company's directors were re-elected at the company's annual meeting on May 29 including Exxon Chairman Darren Woods and Lead...
Nvidia's stock market value hits $3 trillion for first time
Nvidia's stock market value hits $3 trillion for first time
Jun 5, 2024
(Reuters) - Nvidia's ( NVDA ) stock market value hit $3 trillion for the first time on Wednesday as the chipmaker benefited from a race between Wall Street's heavyweights to dominate AI technology. Shares of the maker of specialized AI chips were last up 4.75%. Nvidia ( NVDA ) shares touched an intra-day record high of $1,219.93, giving it a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved